Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$982,609
-$67,016 QoQ
Shares Held
3,869
-9.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#3,036
of 4,676 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mendel Money Management holds $9,330,781 across 7 Drug Manufacturers - General names. JNJ ranks #5 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
12,753 | $3,209,164 | |
| 2 | LLY |
ELI LILLY & Co
|
1,491 | $1,788,350 | |
| 3 | AMGN |
Amgen Inc
|
3,315 | $1,200,427 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,050 | $1,034,425 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
3,869 | $982,609 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
6,125 | $773,832 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,935 | $341,974 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $982,609 | 3,869 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,049,625 | 4,294 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $924,859 | 4,469 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $836,058 | 4,509 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $691,193 | 4,525 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $863,694 | 5,208 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $920,506 | 6,365 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,087,422 | 6,710 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,238,706 | 8,475 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,868,698 | 11,813 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $1,732,603 | 11,054 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,991,263 | 12,785 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,116,173 | 12,785 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,982,760 | 12,792 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,181,980 | 12,352 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,887,134 | 11,552 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,914,622 | 10,786 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,078,976 | 6,088 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $265,671 | 1,553 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $319,124 | 1,976 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $314,323 | 1,908 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $315,223 | 1,918 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $336,478 | 2,138 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $305,650 | 2,053 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $290,822 | 2,068 | Shares | Sole | 2020-07-29 | |
| No filing history on record for this holder in this stock. | ||||||